<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03188926</url>
  </required_header>
  <id_info>
    <org_study_id>0026106</org_study_id>
    <nct_id>NCT03188926</nct_id>
  </id_info>
  <brief_title>Surgical Treatment of Long Bone Metastases</brief_title>
  <acronym>MTC</acronym>
  <official_title>Surgical Treatment for Long Bone Metastases With Intramedullary Nail or Endoprosthetic Reconstruction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istituto Ortopedico Rizzoli</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istituto Ortopedico Rizzoli</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To provide treatment guidelines for patients with long bone metastatic disease based on
      observational study and to propose an algorithm to guide orthopedic surgeons in
      decision-making for these patient.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objectives of this study were to examine clinical outcomes after reconstruction with
      intramedullary fixation (IMN) or endoprosthetic reconstruction (EPR) with a specific focus on
      (1) the rate of complication or failure; (2) differences in complication rates by anatomic
      site; (3) functional results as assessed by the Musculoskeletal Tumor Society System (MSTS);
      (4) differences in complication rate between patients treated with INM versus EPR; and (5)
      differences in survival in patients with metastatic bone disease based on disease-specific,
      laboratory, and demographic information.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 4, 2016</start_date>
  <completion_date type="Anticipated">December 31, 2019</completion_date>
  <primary_completion_date type="Actual">December 31, 2017</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>12 Months</target_duration>
  <primary_outcome>
    <measure>Clinical outcomes after treatment of long bone metastases with intramedullary nail versus endoprosthetic reconstruction</measure>
    <time_frame>1 year</time_frame>
    <description>The objectives of this study were to examine clinical outcomes after reconstruction with intramedullary nail versus endoprosthetic reconstruction with a specific focus on differences in complication rate between patients treated with intramedullary nail versus endoprosthetic reconstruction</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Survival in patients undergoing surgery for metastatic bone disease</measure>
    <time_frame>1 year</time_frame>
    <description>Provide a reliable and objective means of estimating survival in patients with metastatic bone disease based on disease-specific</description>
  </secondary_outcome>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Bone Metastases</condition>
  <condition>Surgery</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>intramedullary fixation or endoprosthetic reconstruction</intervention_name>
    <description>Surgical treatment of impending or pathologic fracture in the extremities</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with long bone metastases treated surgically with intramedullary nail or
        endoprosthetic reconstruction
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  bone metastases of the extremity

        Exclusion Criteria:

          -  bone metastases of the spine
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Davide Donati, MD</last_name>
    <role>Study Director</role>
    <affiliation>Istituto Ortopedico Rizzoli</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Costantino Errani, MD, PhD</last_name>
    <phone>0039 051 6366103</phone>
    <email>costantino.errani@ior.it</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Davide Donati, MD</last_name>
    <phone>0039 051 6366012</phone>
    <email>davidemaria.donati@ior.it</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Istituto Ortopedico Rizzoli</name>
      <address>
        <city>Bologna</city>
        <zip>40136</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Costantino Errani, MD, PhD</last_name>
      <phone>0039 051 6366103</phone>
      <email>costantino.errani@ior.it</email>
    </contact>
    <contact_backup>
      <last_name>Davide Donati, MD</last_name>
      <phone>0039 051 6366012</phone>
      <email>davidemaria.donati@ior.it</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 9, 2017</study_first_submitted>
  <study_first_submitted_qc>June 13, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 16, 2017</study_first_posted>
  <last_update_submitted>March 7, 2018</last_update_submitted>
  <last_update_submitted_qc>March 7, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Istituto Ortopedico Rizzoli</investigator_affiliation>
    <investigator_full_name>Costantino Errani</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasm Metastasis</mesh_term>
    <mesh_term>Bone Neoplasms</mesh_term>
    <mesh_term>Bone Marrow Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>publish a manuscript in international journal</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

